Form 4 for TMO Thermo Fisher Scientific
Accepted 2022-08-29 00:00:00 ET · period of report 2022-08-25 · accession 0001127602-22-021709 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2022-08-29 | 2022-08-25+ | TMO | Lagarde Michel | EVP, COO | F - Tax | $573.76 | -1,275 | 14.1K | -8% | -$731.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-08-26 | F | D | 566 | $563.71 | 14,218.21 | D | — | — | |
| 2 | Common | Common Stock | 2022-08-25 | F | D | 589 | $585.47 | 14,784.21 | D | — | — | |
| 3 | Common | Common Stock | 2022-08-28 | F | D | 120 | $563.71 | 14,098.21 | D | — | — |